Radiation oncology firm Nucletron of Veenendaal, the Netherlands, enjoyed strong financial results over the first half of 2010.
Net sales amounted to 57 million euros ($72.6 million U.S.), an 11.3% increase compared to 51.2 million euros ($65.2 million U.S.) during the first half of 2009. Nucletron attributed the results to growth in the brachytherapy market: Its product sales grew 27% compared to 2009.
The company also has appointed Peter Kingma as its new executive vice president of global sales and service. Kingma has held various positions at Siemens Healthcare of Malvern, PA, including global vice president of sales and marketing for CT in Germany and managing director in Australia and New Zealand. His last position with Siemens was vice president and business manager for the company's U.S. CT division.
Related Reading
Nucletron debuts Oncentra v4.0, July 20, 2010
Nucletron posts record 2009 earnings, May 26, 2010
Nucletron completes German order, May 24, 2010
Nucletron, ART add AccuBoost customer, May 17, 2010
Nucletron names Tarca to VP post, March 2, 2010
Copyright © 2010 AuntMinnie.com
![Overview of the study design. (A) The fully automated deep learning framework was developed to estimate body composition (BC) (defined as subcutaneous adipose tissue [SAT] in liters; visceral adipose tissue [VAT] in liters; skeletal muscle [SM] in liters; SM fat fraction [SMFF] as a percentage; and intramuscular adipose tissue [IMAT] in deciliters) from MRI. The fully automated framework comprised one model (model 1) to quantify different BC measures (SAT, VAT, SM, SMFF, and IMAT) as three-dimensional (3D) measures from whole-body MRI scans. The second model (model 2) was trained to identify standardized anatomic landmarks along the craniocaudal body axis (z coordinate field), which allowed for subdividing the whole-body measures into different subregions typically examined on clinical routine MRI scans (chest, abdomen, and pelvis). (B) BC was quantified from whole-body MRI in over 66,000 individuals from two large population-based cohort studies, the UK Biobank (UKB) (36,317 individuals) and the German National Cohort (NAKO) (30,291 individuals). Bar graphs show age distribution by sex and cohort. BMI = body mass index. (C) After the performance assessment of the fully automated framework, the change in BC measures, distributions, and profiles across age decades were investigated. Age-, sex-, and height-adjusted body composition reference curves were calculated and made publicly available in a web-based z-score calculator (https://circ-ml.github.io).](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/05/body-comp.XgAjTfPj1W.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
